Market access
Market Access Strategy Consulting
Coverage, pricing, reimbursement, and patient support planned as one system before launch.
Definition
What is market access strategy?
Market access strategy is the plan that decides whether eligible patients can obtain a therapy at a price that payers and the manufacturer can both sustain. It aligns pricing, contracting, reimbursement, and patient support so that coverage, affordability, and time to therapy are settled before launch rather than after.
Our market access work starts with payer mix optimization, which shows where patients are covered and where they stall. It continues with J-code crosswalks for physician-administered products and gross-to-net and 340B compliance for the revenue side.
Access programs sit on top of that foundation. See specialty pharmacy and hub optimization for the services that move a patient from prescription to first dose.
Engagements on this topic are led by Osama M. Elhelw, RPh, LSSBB, Managing Partner of HealthBridge Consulting. View credentials and licenses.
| Component | What it covers | Decision it informs |
|---|---|---|
| Payer mix | Share of patients covered by commercial, Medicare, Medicaid, and cash payers, plus 340B channel volume | Where contracting and access programs should focus |
| Gross-to-net | Rebates, chargebacks, fees, and discounts between list price and net revenue | Price and contract guardrails |
| Reimbursement coding | HCPCS J-codes, NDC crosswalks, and billing units | Provider payment accuracy and claim denial rates |
| Patient access programs | Bridge, copay, and free-goods programs | Time to therapy and abandonment |
| Channel and distribution | Specialty pharmacy, buy-and-bill, and direct-to-patient routes | Where patients fill and who is paid |
Our approach
How we will approach market access strategy
Step 01
Baseline the access landscape
- We will map payer coverage, prior authorization criteria, and abandonment points by channel.
- We will measure where gross revenue is lost before it becomes net revenue.
Step 02
Model the economics
- We will build gross-to-net scenarios for each contracting and program option.
- We will test price and contract terms against Medicaid and 340B obligations.
Step 03
Design the access architecture
- We will define program eligibility, routing, and compliance guardrails.
- We will align hub, specialty pharmacy, and field reimbursement roles.
Step 04
Operate and monitor
- We will set governance, service levels, and a shared scorecard.
- We will review results every quarter and adjust before gaps widen.
Deep dives
Go deeper on market access strategy
Market access
Payer mix optimization
See how coverage, denials, and abandonment differ by payer segment, and what each gap costs.
Read the guideMarket access
J-code crosswalks
Map every NDC, package size, and billing unit to the right code before the first claim is filed.
Read the guideMarket access
Gross-to-net and 340B compliance
Model every deduction between list price and net revenue, with 340B obligations in view.
Read the guideQuestions about market access strategy
What is market access in pharma?
Market access is the work of getting an approved therapy covered, reimbursed, and affordable for the patients who need it. It spans payer coverage, pricing and contracting, reimbursement, and patient support.
When should market access planning start?
Planning should start well before launch, usually during late-stage clinical development, because pricing, coding, and channel decisions are hard to change once a product is on the market.
How is market access different from patient access?
Market access focuses on payers, pricing, and coverage policy. Patient access focuses on the services that help an individual patient start and stay on therapy, such as benefits verification, prior authorization support, and copay assistance. Each depends on the other.
Who leads market access engagements at HealthBridge Consulting?
Osama M. Elhelw, RPh, LSSBB, Managing Partner of HealthBridge Consulting, leads engagements. He is a registered pharmacist with more than 17 years of experience in patient access, market access, specialty pharmacy, and pharmaceutical commercialization.
Talk to us about market access strategy
Tell us about your organization and we will respond within 24 business hours.